Sign in
8-K

Current Report

Alaunos Therapeutics, Inc. Filed Acc 0001193125-17-297911

Unregistered share sale · Executive or director change

  • Item 3.02 Unregistered sales of equity securities
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d465084d8k.htm…